Items tagged with Access

Indian civil society pushes for government use compulsory license on MDR-TB drugs (post with simple image)

Advocates appeal to the Prime Minister of India to issue a government use compulsory license for bedaquiline and delamanid to encourage generic competition.

USD 31 million saved by GDF through newly-reduced prices for TB medicines (post with simple image)

The Global Drug Facility’s reduced prices are immediately available to all programs, regardless of their procurement funding source, including: national TB programs, governments, non-governmental organizations, and others.

South Africa makes bedaquiline part of its standard recommended treatment regimen for rifampicin-resistant TB (post with simple image)

Global TB CAB welcomes introduction of safer drug for most South Africans with rifampicin-resistant TB; Other countries and the World Health Organization must now follow.

Treatment Action Group welcomes price reductions for TB medicines (post with simple image)

Countries and donors must do more to ensure all people with TB have access; further price reductions for newer medicines required.

Advocates call on Indian Minister of Health to introduce injection-free drug-resistant TB treatment regimen (post with simple image)

Advocates request that bedaquiline become part of the standard treatment regimen for drug-resistant TB in India.

Advocates call for policies to support all-oral regimens for children with drug-resistant TB (post with simple image)

Advocates release recommendations for injectable-free regimens for children under the age of 12 years.

Activists call on Johnson & Johnson to drop the price of bedaquiline (post with simple image)

Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower.

Activists call on countries and donors to immediately scale up use of life-saving TB LAM test (post with simple image)

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Global TB CAB responds to new bedaquiline price (post with simple image)

The TB CAB reiterates its request for Johnson & Johnson to commit to a global price for bedaquiline that is no higher than US$32 per month.

Blessina Kumar's speech at AIDS 2018 (post with simple image)

Blessina Kumar's speech delivered at the 22nd International AIDS Conference (AIDS 2018), Amsterdam, the Netherlands, 27 July 2018.

Page 55 of 58 · Total posts: 0

←First 54 55 56 Last→